NCT04791969View on ClinicalTrials.gov

Intermittent Oral Naltrexone Enhanced With an Ecological Momentary Intervention for Methamphetamine-using MSM

PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

December 14, 2021

Primary Completion Date

March 1, 2024

Study Completion Date

July 1, 2024

Conditions
Methamphetamine Use Disorder
Interventions
DRUG

Naltrexone Hydrochloride

Intermittent Oral Naltrexone, 50 mg

DRUG

Placebo

Intermittent Oral Placebo

BEHAVIORAL

Ecological Momentary Intervention

"Receive ecological momentary intervention if ecological momentary assessment reports meth craving, stress, not taking study drug, or antecedents detected for high risk meth use."

Trial Locations (1)

94102

San Francisco Department of Public Health, San Francisco

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Glenn-Milo Santos

OTHER

NCT04791969 - Intermittent Oral Naltrexone Enhanced With an Ecological Momentary Intervention for Methamphetamine-using MSM | Biotech Hunter | Biotech Hunter